Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T18:01:53.895Z.
Calculation as of: 2026-10-06T18:01:53.895Z.
Quote observation: 2026-10-06T17:56:10.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: dda5353817af794375b978a2faa289dfa66a026ad884c07a98b38d1ad02c68b2
EARNINGS YIELD
N/A
Market Cap
$104.84M
Earnings Yield
N/A
TTM Avg
0.56%
3Y Avg
0.56%
5Y Avg
0.56%
Market Cap
$106.01M
Earnings Yield
N/A
TTM Avg
9.36%
3Y Avg
9.36%
5Y Avg
9.36%
Market Cap
$103.68M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$106.98M
Earnings Yield
N/A
TTM Avg
0.32%
3Y Avg
0.91%
5Y Avg
2.50%
Market Cap
$107.09M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Definitive Healthcare Corp. (DH) | $105.20M | N/A | N/A | N/A | N/A |
| Anixa Biosciences, Inc. (ANIX)vs › | $104.84M | N/A | 0.56% | 0.56% | 0.56% |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $106.01M | N/A | 9.36% | 9.36% | 9.36% |
| Polaryx Therapeutics, Inc. Common Stock (PLYX)vs › | $103.68M | N/A | N/A | N/A | N/A |
| Vivani Medical, Inc. (VANI)vs › | $106.93M | N/A | N/A | N/A | N/A |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $106.98M | N/A | 0.32% | 0.91% | 2.50% |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $107.09M | N/A | N/A | N/A | N/A |
| OnKure Therapeutics, Inc. (OKUR)vs › | $103.27M | N/A | N/A | N/A | N/A |
| Outlook Therapeutics, Inc. (OTLK)vs › | $107.32M | N/A | N/A | N/A | N/A |
| Immunic, Inc. (IMUX)vs › | $107.47M | N/A | N/A | N/A | N/A |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
